Talk:Alectinib
Latest comment: 6 years ago by Rod57 in topic How does it differ from crizotinib to explain the better results
| This is the talk page for discussing improvements to the Alectinib article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Alectinib.
|
How does it differ from crizotinib to explain the better results
editIs there enough material for a Mechanism of action section ? - Rod57 (talk) 19:06, 11 February 2016 (UTC)
Is it more selective (less off-target interactions and side-effects) than crizotinib ? (crizotinib apparently also inhibits ROS1) - Rod57 (talk) 18:06, 8 December 2017 (UTC)